Speaker(s): 

Anthony Noto, MD Staff Member, Geisinger - has no disclosures

Learning Objectives: 

•  identify the evidence supporting the use of Tenecteplase over alteplase for acute ischemic stroke
• recognize the expanded patient population that can benefit from mechanical thrombectomy
•  recognize the role of dual antiplatelet therapy in secondary stroke prevention
• describe optimal timing for resuming/initiating AC after ischemic stroke
•  state the role and evidence supporting vagus nerve stimulation post-stroke
•   list the key stroke quality metrics and understand the importance of metric-based care in stroke

The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None